Trial site
Hospital Victoria Eugenia De La Cruz Roja Espanola
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease13 trials
- Mild cognitive impairment4 trials
- Parkinson disease1 trial
- Schizophrenia1 trial
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 11 trial
- Status
- Recruiting6 trials
- Active, not recruiting5 trials
- Completed3 trials
- Lead sponsor
- Bristol-Myers Squibb3 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- AbbVie1 trial
- Acumen Pharmaceuticals1 trial
- Biogen1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease5 recruiting
- Parkinson disease1 recruiting
- Schizophrenia1 recruiting
Closed trials
Active, not recruiting
Completed
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026